Jim Jinn-Chyuan Sheu

Jim Jinn-Chyuan Sheu

Auto-generated profile, based on publicly available information

Jim Jinn-Chyuan Sheu

Human Genetic Center, China Medical University Hospital, Taichung, Taiwan

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 February 2011 in The Journal of Pathology
Verified
Journal Article
Closed access
PDF file
MLMing‐Tsung Lai
Ming‐Tsung Lai
CHChun‐Hung Hua
Chun‐Hung Hua
MTMing‐Hsui Tsai
Ming‐Hsui Tsai
LWLei Wan
Lei Wan
YLYing‐Ju Lin
Ying‐Ju Lin
JSJim Jinn‐Chyuan Sheu
Jim Jinn‐Chyuan Sheu

1 December 2010 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
JSJim Jinn-Chyuan Sheu
Jim Jinn-Chyuan Sheu
BGBin Guan
Bin Guan
JCJung-Hye Choi
Jung-Hye Choi
ALAthena Lin
Athena Lin
Chia-Huei LeeChia-Huei Lee
Chia-Huei Lee
ISIe-Ming Shih
Ie-Ming Shih
Rsf-1 (HBXAP) has been reported as an amplified gene in human cancer, including the highly aggressive ovarian serous carcinoma. Rsf-1 protein interacts with SNF2H to form an ISWI chromatin remodeling complex, RSF. In this study, we investigated the functional role of Rsf-1 by observing phenotypes after expressing it in nontransformed cells. Acute expression of Rsf-1 resulted in DNA damage as evidenced by DNA strand breaks, nuclear γH2AX foci, and activation of the ATM-CHK2-p53-p21 pathway, leading to growth arrest and apoptosis. Deletion mutation and gene knockdown assays revealed that formation of a functional RSF complex with SNF2H was required for Rsf-1 to trigger DNA damage response (DDR). Gene knock-out of TP53 alleles, TP53 mutation, or treatment with an ATM inhibitor abolished up-regulation of p53 and p21 and prevented Rsf-1-induced growth arrest. Chronic induction of Rsf-1 expression resulted in chromosomal aberration and clonal selection for cells with c-myc amplification and CDKN2A/B deletion. Co-culture assays indicated Rsf-1-induced DDR as a selecting barrier that favored outgrowth of cell clones with a TP53 mutation. The above findings suggest that increased Rsf-1 expression and thus excessive RSF activity, which occurs in tumors harboring Rsf-1 amplification, can induce chromosomal instability likely through DDR.

1 May 2011 in The American Journal of Pathology
Verified
Journal Article
Closed access
FFFu-Min Fang
Fu-Min Fang
CLChien-Feng Li
Chien-Feng Li
HHHsuan-Ying Huang
Hsuan-Ying Huang
MLMing-Tsong Lai
Ming-Tsong Lai
CCChih-Mei Chen
Chih-Mei Chen
JSJim Jinn-Chyuan Sheu
Jim Jinn-Chyuan Sheu

4 February 2013 in The Journal of Pathology
Verified
Journal Article
Closed access
PDF file
JSJim Jinn‐Chyuan Sheu
Jim Jinn‐Chyuan Sheu
JCJung-Hye Choi
Jung-Hye Choi
BGBin Guan
Bin Guan
FTFuu‐Jen Tsai
Fuu‐Jen Tsai
CHChun‐Hung Hua
Chun‐Hung Hua
ISIe-Ming Shih
Ie-Ming Shih

1 March 2012 in The American Journal of Pathology
Verified
Journal Article
Closed access
JSJim Jinn-Chyuan Sheu
Jim Jinn-Chyuan Sheu
BGBin Guan
Bin Guan
FTFuu-Jen Tsai
Fuu-Jen Tsai
EHErin Yi-Ting Hsiao
Erin Yi-Ting Hsiao
CCChih-Mei Chen
Chih-Mei Chen
ISIe-Ming Shih
Ie-Ming Shih

5 December 2013 in PLOS ONE
Verified
Journal Article
Open access
PDF file
CCCherry Yin-Yi Chang
Cherry Yin-Yi Chang
YCYi Chen
Yi Chen
MLMing-Tsung Lai
Ming-Tsung Lai
HCHui-Wen Chang
Hui-Wen Chang
JCJack Cheng
Jack Cheng
FTFuu-Jen Tsai
Fuu-Jen Tsai
Bone morphogenetic protein receptor I B (BMPR1B) is a transmembrane receptor mediating TGF-β signal transduction. Recent studies indicate a tumor suppressor role for BMPR1B in ovarian cancer. Polymorphism at BMPR1B 3′UTR within the miR-125b binding site alters its binding affinity toward the miRNA, which may result in insufficient post-transcriptional repression. Single-nucleotide polymorphisms rs1970801, rs1434536, and rs11097457 near the miR-125b binding site in BMPR1B were genotyped by Taqman assay on 193 endometriosis patients and 202 healthy controls. BMPR1B and CA125 levels in ectopic endometrial tissues were evaluated by quantitative PCR and immunohistochemistry. Luciferase reporter assay was utilized to verify regulatory roles of BMPR1B 3′UTR with allelic variants of rs1434536 in a cell line model. Cell proliferation and migration were recorded, while expression of BMPR1B, CA125, glucocorticoid receptor (GCCR) and IL-1β were measured by quantitative PCR in endometrial cells transfected with wild-type or mutated miR-125b. This study found two endometriosis-associated SNPs, rs1434536 (P = 0.010) and rs1970801 (P = 0.0087), located within and next to a miR-125b binding site on BMPR1B. Interestingly, patients with homozygous variant alleles at rs1434536 showed significantly lower serum CA125 levels. Immunohistochemistry staining further confirmed inverse correlation between BMPR1B and CA125 levels in three rs1434536 genotypes. Cell assays demonstrated the variant allele of rs1434536 up-regulating BMPR1B at both mRNA and protein levels, which negatively correlated with CA125 and IL-1β levels. Disruption of the binding between miR-125b and BMPR1B hampered abnormal cell proliferation. SNPs of BMPR1B within and next to the miR-125b binding site manifested strong correlation with endometriosis development in a Taiwanese cohort. Disrupting the binding of miR-125b toward BMPR1B would increase protein expression, diminishing abnormal cell proliferation as well as serum and cellular CA125 levels. Genetic variation at the miR-125b binding site may play functional roles to protect against endometriosis progression.